Renal consequences of obesity

Case Reports and Clinical Practice Review

Volumn 16, Issue 8, 2010, Pages

  Naumnik, Beata ^a   Myśliwiec, Michał ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Obesity; Obesity related glomerulopathy; Obesity related hypertension; Secondary FSGS

Indexed keywords

ANTIOBESITY AGENT; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; SODIUM;

ADIPOSE TISSUE; ADRENERGIC SYSTEM; ARTICLE; AWARENESS; CARDIOVASCULAR DISEASE; CYTOKINE RELEASE; DISEASE ASSOCIATION; EXERCISE; FOCAL GLOMERULOSCLEROSIS; GASTRIC BANDING; GLOMERULOPATHY; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HORMONE RELEASE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; KIDNEY INJURY; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE PRESSURE; LIPID STORAGE; METABOLIC DISORDER; MORBIDITY; MORTALITY; NATRIURESIS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; PROTEINURIA; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SODIUM ABSORPTION; SODIUM RESTRICTION; STOMACH BYPASS; WEIGHT GAIN; WEIGHT REDUCTION; ANIMAL; KIDNEY; REVIEW; ARTERIAL PRESSURE; CARDIOVASCULAR RISK; DISEASE CLASSIFICATION; GENETIC RISK; HEART DEATH; HEART INJURY; KIDNEY DYSFUNCTION; PREVENTION AND CONTROL; SODIUM RETENTION;

ANIMALS; HUMANS; KIDNEY; KIDNEY DISEASES; OBESITY; WEIGHT LOSS;

EID: 77955326473     PISSN: 15076164     EISSN: 16433742     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Ogden CL, Flegal KM, Carroll MD, Johnson CL: Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA, 2002; 288: 1728-32.
2. Strauss RS, Pollack HA: Epidemic Increase in Childhood Overweight, 1986-1998. JAMA, 2001; 286: 2845-48.
3. Dietz WH, Robinson TN: Clinical practice. Overweight children and adolescents. N Engl J Med, 2005; 352: 2100-9.
4. Flodmark CE, Lissau I, Moreno LA et al: New insights into the field of children and adolescents' obesity: the European perspective. Int J Obes Relat Metab Disord, 2004; 28: 1189-96.
5. Deurenberg P, Weststrate JA, Seidell JC: Body mass index as a measure of body fatness: ageand sex-specific prediction formulas. Br J Nutr, 1991; 65: 105-14.
6. Baker S, Barlow SS, Cochran W et al: Overweight children and adolescents: a clinical report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr, 2005; 40: 533-43.
7. Ogden CL, Carroll MD, Flegal KM: High body mass index for age among US children and adolescents, 2003-2006. JAMA, 2008; 299: 2401-5.
8. Anderson SE, Whitaker RC: Prevalence of obesity among US preschool children in different racial and ethnic groups. Arch Pediatr Adolesc Med, 2009; 163: 344-48.
9. Obesity prevalence among low-income, preschool-aged children United States, 1998-2008. MMWR Morb Mortal Wkly Rep, 2009; 58: 769
10. Mitchell RT, McDougall CM, Crum JE: Decreasing prevalence of obesity in primary schoolchildren. Arch Dis Child, 2007; 92: 153-54.
11. Garn SM, Cole PE: Do the obese remain obese and the lean remain lean? Am J Public Health, 1980; 70: 351-53.
12. Bremer AA, Auinger P, Byrd S: Relationship between insulin resistanceassociated metabolic parameters and anthropometric measurements with sugar-sweetened beverage intake and physical activity levels in US ado-lescents: findings from the 1999-2004 National Health and Nutrition Examination Survey. Arch Pediatr Adolesc Med, 2009; 163: 328-35.
13. Malik VS, Schulze MB, Hu FB: Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr, 2006; 84: 274-88.
14. Ebbeling CB, Feldman HA, Osganian SK et al: Effects of decreasing sugar-sweetened beverage consumption on body weight in adolescents: a randomized, controlled pilot study. Pediatrics, 2006; 117: 673-80.
15. Menschik D, Ahmed S, Alexander MH, Blum RW: Adolescent physical activities as predictors of young adult weight. Arch Pediatr Adolesc Med, 2008; 162: 29-33.
16. Ludwig DS, Gortmaker SL: Programming obesity in childhood. Lancet, 2004; 364: 226-27.
17. Epstein LH, Roemmich JN, Robinson JL et al: A randomized trial of the effects of reducing television viewing and computer use on body mass index in young children. Arch Pediatr Adolesc Med, 2008; 162: 239-45.
18. Epstein LH, Roemmich JN, Paluch RA, Raynor HA: Influence of changes in sedentary behavior on energy and macronutrient intake in youth. Am J Clin Nutr, 2005; 81: 361-66.
19. Stettler N, Signer TM, Suter PM: Electronic games and environmental factors associated with childhood obesity in Switzerland. Obes Res, 2004; 12: 896-903.
20. Jiang F, Zhu S, Yan C et al: Sleep and obesity in preschool children. J Pediatr, 2009; 154: 814-18.
21. Cappuccio FP, Taggart FM, Kandala NB et al: Meta-analysis of short sleep duration and obesity in children and adults. Sleep, 2008; 31: 619-26.
22. Speiser PW, Rudolf MC, Anhalt H et al: Childhood obesity. J Clin Endocrinol Metab, 2005; 90: 1871-87.
23. Reinehr T, Hinney A, de Sousa G et al: Definable somatic disorders in overweight children and adolescents. J Pediatr, 2007; 150: 618-22.
24. Leunissen RW, Kerkhof GF, Stijnen T, Hokken-Koelega A: Timing and tempo of first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood. JAMA, 2009; 301: 2234-42.
25. Gardner DS, Hosking J, Metcalf BS et al: Contribution of early weight gain to childhood overweight and metabolic health: a longitudinal study (EarlyBird 36). Pediatrics, 2009; 123: e67
26. Ong KK, Northstone K, Wells JC et al: Earlier Mother's Age at Menarche Predicts Rapid Infancy Growth and Childhood Obesity. PLoS Med, 2007; 4: e132
27. Kissebah AH, Krakowem GR: Regional adiposity and morbidity. Physiol Rev, 1994; 74: 761-811.
28. Bjorntorp P: Metabolic implication of body fat distribution. Diabetic Care, 1991; 14: 1132-43.
29. Weisinger JR, Kempson RL, Eldridge L, Swenson RS: The nephritic syndrome: A complication of massive obesity. Ann Intern Med, 1974; 81: 440-47.
30. Chen J Gu D, Chen CS et al: Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transplant, 2007; 22: 1100-6.
31. Navarro-Diaz M, Serra A, Romero R et al: Effects of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol, 2006; 17 (12 Suppl.3): S213-17.
32. Ishizaka Y, Ishizaka N, Tani M et al: Association between changes In obesity parameters and incidence of chronic kidney disease in Japanese individuals. Kidney Blood Press Res, 2009; 32: 141-49.
33. Fox CS, Larson MG, Leip EP et al: Predictors of new-onset kidney disease in a community-based population. JAMA, 2004; 291: 844-50.
34. Iseki K, Ikemiya Y, Kinjo K et al: Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int, 2004; 65: 1870-76.
35. Pinto-Sietsma SJ, Navis G, Janssen WM et al: A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis, 2003; 41: 733-41.
36. Hall JE: The kidney, hypertension, and obesity. Hypertension, 2003; 4: 625-33.
37. Hall JE, Brands MW, Henegar JR: Mechanisms of hypertension and kidney disease in obesity. Ann N Y Acad Sci, 1999; 892: 91-107.
38. Hall JE, Cook ED, Jones DW et al: Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci, 2002; 324: 127-37.
39. Hall JE: Pathophysiology of obesity hypertension. Curr Hypertens Rep, 2000; 2: 139-47.
40. Hall JE, Hildebrandt DA, Kuo J: Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens, 2001; 14: 103S-15
41. Hall JE, Brands MW, Dixon WN, Smith MJ Jr: Obesity-induced hypertension: renal function and systemic hemodynamics. Hypertension, 1993; 22: 292-99.
42. Hall JE: Mechanisms of abnormal renal sodium handling in obesity hepertension. Am J Hypertens, 1997; 10: S49-55.
43. Hall JE: Hyperinsulinemia: a link between obesity ad hypertension? Kidney Int, 1993; 43: 1402-17.
44. Esler M: The sympathetic system and hypertension. Am J Hypertens, 2000; 13: 99S-105S
45. Kassab S, Kato T Wilkins C et al: Renal denervation attenuates the sodium retension and hypertension associated with obesity. Hypertension, 1995; 25: 893-97.
46. Shek EW, Brands MW, Hall JE: Chronic leptin infusion increases arterial pressure. Hypertension, 1998; 31: 409-14.
47. Mark AL, Shaffer RA, Correia ML et al: Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow mice. J Hypertens, 1999; 17: 1949-53.
48. Haynes WG, Morgan DA, Djalal WL, Mark AL: Interaction between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension, 1999; 33: 1243-52.
49. Hall JE, Henegar JR, Shek EW, Brands MW: Role of rennin-angiotensin system in obesity hypertension. Circulation, 1997; 96: I-33
50. Mogensen CE: The reno-protective role of AT(1)-receptors blockers. J Hum Hypertens, 2002; 16: S52-58.
51. Nagase M, Yoshida S, Shibata S et al: Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J Am Soc Nephrol, 2006; 17: 3438-46.
52. Ritz E: Metabolic syndrome and kidney disease. Blood Purif, 2008; 26: 59-62.
53. Dwyer TM, Banks SA, Alonso-Galicia M et al: Distribution of renal medullary hyaluronan in lean and obese rabbits. Kidney Int, 2000; 58: 721-29.
54. Thalmann S, Meier CA: Local adipose tissue depots as cardiovascular risk factors. Cardiovasc Res, 2007; 75: 690-701.
55. Ronti T, Lupattelli G, Mannarino E: The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf), 2006; 64: 355-65.
56. Kambham N, Markowitz GS, Valeri AM et al: Obesity-related glomerulopathy: An emerging epidemic. Kidney Int, 2001; 59: 1498-509.
57. Goumenos DS, Kawar B, El Nahas M et al: Early histological changes in the kidney of people with morbid obesity. Nephrol Dial Transplant, 2009: 24(12): 3732-38.
58. Schwimmer JA, Markowitz GS, Valeri AM et al: Secondary focal segmental glomerulosclerosis in non-obese patients with increased mus-cle mass. Clin Nephrol, 2003; 60(4): 233-41.
59. Frystyk J, Skjaerbaek C, Vesto E et al: Circulating levels of free insulinelike growth factors in obese subjects: The impact of type 2 diabetes. Diabetes Metab Res Rev, 1999; 15: 314-22.
60. Wolf G, Hamman A, Han DC et al: Leptin stimulates proliferation and TGF-b expression in renal glomerular endothelial cells: potential role in gloemrulosclerosis. Kidney Int, 1999; 56: 860-72.
61. Joles JA, Kunter U, Janssen U et al: Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol, 2000; 11: 669-83.
62. Dwyer TM, Banks SA, Alonso-Galicia M et al: Distribution of renal medullary hyaluronan in lean and obese rabbits. Kidney Int, 2000; 58: 721-29.
63. Navaneethan SD, Yehnert H, Moustarah F et al: Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol, 2009; 4(10): 1565-74